Hytracin
Brand names,
Hytracin
Analogs
Hytracin
Brand Names Mixture
Hytracin
Chemical_Formula
C19H25N5O4
Hytracin
RX_link
http://www.rxlist.com/cgi/generic/teraz.htm
Hytracin
fda sheet
Hytracin
msds (material safety sheet)
Hytracin
Synthesis Reference
M. Winn et al., U.S. Pat. 4,026,894 (1977)
Hytracin
Molecular Weight
387.433 g/mol
Hytracin
Melting Point
273 oC
Hytracin
H2O Solubility
29.7mg/mL
Hytracin
State
Solid
Hytracin
LogP
0.875
Hytracin
Dosage Forms
Tablet
Hytracin
Indication
For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.
Hytracin
Pharmacology
Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia.
Hytracin
Absorption
Essentially completely absorbed in man (90% bioavailability).
Hytracin
side effects and Toxicity
LD50=259.3mg/kg (i.v. in mice)
Hytracin
Patient Information
Hytracin
Organisms Affected
Humans and other mammals